Major players in the minimally invasive surgery devices market are Abbott Laboratories, GE Healthcare, Medtronic PLC, Siemens Healthineers, Smith & Nephew Plc. , Medtronic Plc. , Stryker Corporation, Boston Scientific Corporation, Ethicon Inc, and B.
New York, May 27, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Minimal Invasive Surgery Devices Global Market Report 2022" - https://www.reportlinker.com/p06280849/?utm_source=GNW
Braun Melsungen AG.
The global minimal invasive surgery devices market is expected to grow from $26.04 billion in 2021 to $28.98 billion in 2022 at a compound annual growth rate (CAGR) of 11.3%. The market is expected to grow to $36.61 billion in 2026 at a compound annual growth rate (CAGR) of 6%.
The minimally invasive surgery devices market consists of sales of minimally invasive surgical devices and related services. The minimally invasive surgery devices are used to minimize the surgical incisions and trauma in the body.
The main product types of minimally invasive surgery devices are handheld instruments, inflation devices, cutter instruments, guiding devices, electrosurgical devices, auxiliary devices, monitoring and visualization devices.The electrosurgical devices are used to destroy tissue, incise tissue, and control bleeding by coagulating blood.
The various applications of minimal invasive surgery devices are laparoscopy, cardiovascular, cosmetic surgery, orthopedic surgery, obstetrics and gynecology, ophthalmology, neurosurgery, urology, and others that are used by end-users such as hospitals, ambulatory surgical centers (ASCS), and research institutes.
The increasing awareness for minimally invasive surgeries among people is driving the minimally invasive surgery devices market.The minimally invasive surgeries require less/tiny cuts in the skin as compared to traditional surgical methods and aid in lesser pain, short hospital stay, less scarring, minimized chances of bleeding and infections, and low tissue damage.
According to the German Heart Surgery Report, the heart operations using ECC (extracorporeal circulation) declined due to achievement of established innovations in minimally invasive therapeutic options in heart surgeries. Furthermore, 51.1% of heart valve operations performed out of the total cardiac surgical procedures in Germany were through the single-valve procedure, out of which 38.5% of them were through minimal invasive heart surgeries. Thus, the growing demand for minimally invasive surgery (MIS) will increase the demand for the minimally invasive surgical devices market.
The rising trade barriers are expected to have a negative impact on the minimally invasive surgery devices market growth.Many countries placed trade restrictions, especially on imports, to boost local production.
For instance, Brexit is likely to lead to more trade restrictions between the UK and other countries in Europe.The US is also implementing several trade restrictions, especially with China, to boost its local production.
For instance, the US government imposed an additional 25% tariff on approximately $16 billion worth of imports from China, including minimally invasive surgical devices and equipment and supplies. These trade restrictions are likely to limit the growth of demand going forward by leading to raised prices.
Technologically advanced minimally invasive surgery (MIS) devices with improvements in image guidance, fiber-optics, mini dental implants, and robotic control systems are increasingly opted by patients to treat medical conditions such as aneurysms, cardiac procedures, dental and spinal procedures.Less-invasive surgical procedures with enhanced capabilities in the areas of imaging, micromachining, robotic equipment and components, software systems, and others are becoming popular in the healthcare industry.
For instance, video-assisted thoracoscopic surgery (VATS), is a minimally invasive surgical procedure performed to completely remove an organ of the human body to treat traumatic injury, infection, or cancer in the lungs.VATS is performed using a video camera where a small tube called a thoracoscope to which the camera is connected, is inserted through a small incision between the ribs.
Furthermore, imaging technology involved in MIS, virtual reality (VR) is becoming a significant area of development. Other MIS techniques are applied to perform surgeries such as single-site laparoscopic surgery, robotic surgeries, needlescopic surgery, cardiac and spinal surgeries, and others.
Food and Drug Administration Act (FDA) regulates the minimally invasive surgical devices market in the United States of America.The firms manufacturing robotic minimally invasive surgical devices have to list down any possible risks to health and measures taken by them so that the device addresses health hazards if any stated by FDA.
In December 2019, FDA released a safety communication, regards the caution when using robotically-assisted minimally invasive surgical devices in women’s health including mastectomy and other cancer-related surgeries. However, the FDA is concerned about the health care providers and patients for not being aware of the safety and effectiveness of these devices as they should not be used in mastectomy procedures or prevention or treatment of cancer.
The regions covered in this report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.
The countries covered in the minimally invasive surgery devices market are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA.
Read the full report: https://www.reportlinker.com/p06280849/?utm_source=GNW
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
CONTACT: Clare: email@example.com US: (339)-368-6001 Intl: +1 339-368-6001